Previous research demonstrated that primary tumor cells undergoing EMT, namely losing expression of epithelial markers (e.g., E-Cadherin and EpCAM) and acquiring mesenchymal markers including N-Cadherin, tend to be more aggressive and apt to metastasis28, 29. The gene discussed is EPCAM; the disease is neoplasm.